Illumina beats Q4 adjusted EPS estimates

Illumina

05/02/2026 21:16

Overview

DNA sequencing firm's Q4 revenue rose 5%, adjusted EPS beat analyst expectations

Company completed SomaLogic acquisition, expanding multiomics portfolio

Fiscal 2026 revenue expected to grow 4% to 6%

Outlook

Illumina expects fiscal year 2026 revenue between $4.5 bln and $4.6 bln

Company forecasts non-GAAP diluted EPS of $5.05 - $5.20 for fiscal year 2026

Illumina anticipates non-GAAP operating margin of 23.3% - 23.5% in 2026

Result Drivers

CLINICAL MARKET GROWTH - Illumina saw increased adoption of NGS-based testing in clinical markets, contributing to Q4 revenue growth

SOMALOGIC ACQUISITION - The acquisition of SomaLogic is expected to add 1.5% - 2.0% to fiscal 2026 revenue growth

CHINA MARKET PROGRESS - Illumina achieved progress in China with the lifting of the export ban on sequencers, though challenges remain due to its inclusion on the Unreliable Entities List

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Adjusted EPS
Beat
$1.35
$1.23 (16 Analysts)
Q4 EPS
$2.16
Q4 Adjusted Net Income
Beat
$208 mln
$189.72 mln (14 Analysts)
Q4 Net Income
$334 mln
Q4 Gross Margin
65.50%
Q4 Adjusted EBIT Margin
23.70%
Q4 Adjusted Gross Margin
67.00%
Q4 EBIT Margin
17.40%


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 8 "strong buy" or "buy", 9 "hold" and 3 "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

Wall Street's median 12-month price target for Illumina Inc is $131.00, about 2.4% below its February 4 closing price of $134.19

The stock recently traded at 26 times the next 12-month earnings vs. a P/E of 25 three months ago

Press Release: ID:nPn22YyLga

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)